Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance. 2021

Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Circular RNAs (circRNAs) are covalently closed RNA molecules that play important regulatory roles in various tumors. Prostate cancer (PCa) is one of the most common malignant tumors in the world, with high morbidity and mortality. In recent years, more and more circRNAs have been found to be abnormally expressed and involved in the occurrence and development of PCa, including cell proliferation, apoptosis, invasion, migration, metastasis, chemotherapy resistance, and radiotherapy resistance. Most of the circRNAs regulate biological behaviors of cancer through a competitive endogenous RNA (ceRNA) regulatory mechanism, and some can exert their functions by binding to proteins. circRNAs are also associated with many clinicopathological features of PCa, including tumor grade, lymph node metastasis, and distant metastasis. In addition, circRNAs are potential diagnostic and prognostic biomarkers for PCa. Considering their critical regulatory roles in the progression of PCa, circRNAs would be the potential therapeutic targets. In this paper, the current research status of circRNAs in PCa is briefly reviewed.

UI MeSH Term Description Entries

Related Publications

Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
April 2020, Trends in cancer,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
June 2023, Experimental and molecular pathology,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
February 2023, International journal of molecular sciences,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
June 2020, Cells,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
June 2021, Cancer biology & medicine,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
August 2021, Journal of hematology & oncology,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
July 2021, Cancers,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
September 2021, Cellular and molecular life sciences : CMLS,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
December 2021, Molecular therapy oncolytics,
Xiao Liu, and Yonghua Tong, and Ding Xia, and Ejun Peng, and Xiaoqi Yang, and Hailang Liu, and Tao Ye, and Xinguang Wang, and Yu He, and Zhangqun Ye, and Zhiqiang Chen, and Kun Tang
March 2022, Molecular therapy. Nucleic acids,
Copied contents to your clipboard!